Report cover image

Karo Pharma AB - Strategic SWOT Analysis Review

Publisher GlobalData
Published Dec 27, 2023
Length 38 Pages
SKU # GBDT18438074

Description

Karo Pharma AB - Strategic SWOT Analysis Review


- provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – GlobalData’s summarization of the company’s business strategy.
  • SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
Highlights

Karo Healthcare AB (Karo Healthcare), formerly Karo Pharma AB, is a healthcare company which focuses on development and commercialization of pharmaceutical products. The company provides prescription medicines and over the counter products to pharmacies and directly to the healthcare sector across various countries with the Nordic region and Europe as its core markets. Karo Pharma has developed BabySlide, a product that is developed to reduce stretch marks during childbirth. The company has brands spanning six key categories which include intimate care, dermatology, foot care, wellness, Rx pharma care, pain, cough & cold. Karo Pharma AB is headquartered in, Stockholm, Sweden.

Karo Pharma AB Key Recent Developments

Jul 03,2023: Babak Peyami Joins Karo’s Corporate Management Team as new Head of Digital Commerce
Jan 16,2023: Michael Kaltenborn appointed CSDO at Karo
Jul 21,2022: Karo Pharma : Interim report H1 2022
Apr 12,2022: Karo Pharma publishes the 2021 annual report

Reasons to Buy
  • Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
  • Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
  • Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
  • Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Note:Some sections may be missing if data is unavailable for the company.

Table of Contents

38 Pages
List of Tables
List of Figures
Section 1 - About the Company
Karo Pharma AB - Key Facts
Karo Pharma AB - Key Employees
Karo Pharma AB - Key Employee Biographies
Karo Pharma AB - Major Products and Services
Karo Pharma AB - History
Karo Pharma AB - Company Statement
Karo Pharma AB - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Karo Pharma AB - Business Description
Business Segment: Digital First
Overview
Performance
Business Segment: OTC
Overview
Performance
Business Segment: Rx
Overview
Performance
Geographical Segment: Denmark
Performance
Geographical Segment: Finland
Performance
Geographical Segment: France
Performance
Geographical Segment: Germany
Performance
Geographical Segment: Italy
Performance
Geographical Segment: Norway
Performance
Geographical Segment: Rest of Europe
Performance
Geographical Segment: Rest of World
Performance
Geographical Segment: Sweden
Performance
Geographical Segment: USA
Performance
Karo Pharma AB - Corporate Strategy
Karo Pharma AB - SWOT Analysis
SWOT Analysis - Overview
Karo Pharma AB - Strengths
Karo Pharma AB - Weaknesses
Karo Pharma AB - Opportunities
Karo Pharma AB - Threats
Karo Pharma AB - Key Competitors
Section 3 – Company’s Lifesciences Financial Deals and Alliances
Karo Pharma AB, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
Karo Pharma AB, Pharmaceuticals & Healthcare, Deals By Type, 2017 to YTD 2023
Karo Pharma AB, Recent Deals Summary
Section 4 – Company’s Recent Developments
Jul 03, 2023: Babak Peyami Joins Karo’s Corporate Management Team as new Head of Digital Commerce
Jan 16, 2023: Michael Kaltenborn appointed CSDO at Karo
Jul 21, 2022: Karo Pharma : Interim report H1 2022
Apr 12, 2022: Karo Pharma publishes the 2021 annual report
Feb 25, 2022: Karo Pharma : Year-end report 2021
Section 5 – Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Karo Pharma AB, Key Facts
Karo Pharma AB, Key Employees
Karo Pharma AB, Key Employee Biographies
Karo Pharma AB, Major Products and Services
Karo Pharma AB, History
Karo Pharma AB, Subsidiaries
Karo Pharma AB, Key Competitors
Karo Pharma AB, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
Karo Pharma AB, Pharmaceuticals & Healthcare, Deals By Type, 2017 to YTD 2023
Karo Pharma AB, Recent Deals Summary
List of Figures
Karo Pharma AB, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
Karo Pharma AB, Pharmaceuticals & Healthcare, Deals by Type, 2017 to YTD 2023

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us